JP2025084976A5 - - Google Patents

Info

Publication number
JP2025084976A5
JP2025084976A5 JP2025034492A JP2025034492A JP2025084976A5 JP 2025084976 A5 JP2025084976 A5 JP 2025084976A5 JP 2025034492 A JP2025034492 A JP 2025034492A JP 2025034492 A JP2025034492 A JP 2025034492A JP 2025084976 A5 JP2025084976 A5 JP 2025084976A5
Authority
JP
Japan
Prior art keywords
initiation
treatment
monthly
administrations
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025034492A
Other languages
English (en)
Japanese (ja)
Other versions
JP7852107B2 (ja
JP2025084976A (ja
Filing date
Publication date
Priority claimed from JP2022000341A external-priority patent/JP7273204B2/ja
Application filed filed Critical
Publication of JP2025084976A publication Critical patent/JP2025084976A/ja
Publication of JP2025084976A5 publication Critical patent/JP2025084976A5/ja
Application granted granted Critical
Publication of JP7852107B2 publication Critical patent/JP7852107B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2025034492A 2018-02-06 2025-03-05 眼科疾患の処置 Active JP7852107B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862627103P 2018-02-06 2018-02-06
US62/627,103 2018-02-06
US201862729333P 2018-09-10 2018-09-10
US62/729,333 2018-09-10
JP2022000341A JP7273204B2 (ja) 2018-02-06 2022-01-05 眼科疾患の処置
JP2023073187A JP7646727B2 (ja) 2018-02-06 2023-04-27 眼科疾患の処置

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023073187A Division JP7646727B2 (ja) 2018-02-06 2023-04-27 眼科疾患の処置

Publications (3)

Publication Number Publication Date
JP2025084976A JP2025084976A (ja) 2025-06-03
JP2025084976A5 true JP2025084976A5 (https=) 2026-01-08
JP7852107B2 JP7852107B2 (ja) 2026-04-27

Family

ID=

Similar Documents

Publication Publication Date Title
JP2023099094A5 (https=)
KR102412023B1 (ko) 레날리도마이드 또는 포말리도마이드 및 ｃｄ38 항체-감쇠 인터페론-알파 구성체의 조합, 및 이의 용도
US20100047204A1 (en) Use of organic compounds
CN109715189B (zh) 靶向VE-PTP(HPTP-β)的人源化单克隆抗体
IL276383B2 (en) Treatment of ophthalmologic diseases
CN111787981B (zh) 增加肌肉量和减少脂肪量的方法
JP2010502208A (ja) 半減期の長い血清アルブミン結合タンパク質
CN114558129A (zh) 用于降低心血管风险的方法
JP2025530139A (ja) 抗ＦｃＲＮ抗体を用いた慢性炎症性脱髄性多発神経障害の治療方法
CN110913889A (zh) 通过施用pcsk9抑制剂治疗糖尿病患者中的高脂血症的方法
JP2019521156A5 (https=)
JP2022062153A (ja) デュラグルチドを使用する方法およびデュラグルチドを含有する組成物
JP7722991B2 (ja) 抗ｆｃｒｎ抗体を用いた温熱自己免疫性溶血性貧血の治療方法
JP2021523881A5 (https=)
CN116710137A (zh) 用于在治疗眼部疾病的方法中使用的vegf拮抗剂
JP2025084976A5 (https=)
JP2025084977A5 (https=)
EP3868396A1 (en) Inhibitors and uses thereof
JPWO2022245739A5 (https=)
JP7849919B2 (ja) ヒトｄｒ３に特異的に結合する抗体及びその用途
WO2021018191A1 (zh) Il-17拮抗剂治疗自身免疫疾病的方法
JPWO2021228987A5 (https=)
JPWO2019186369A5 (https=)
WO2018096467A1 (en) Methods of treating acne using interleukin-17 (il-17) antagonists
TW202608918A (zh) 雙鏈構建體的配對